These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11267541)

  • 21. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosing benign prostatic hyperplasia versus prostate cancer.
    Denis LJ
    Br J Urol; 1995 Jul; 76 Suppl 1():17-23. PubMed ID: 7544211
    [No Abstract]   [Full Text] [Related]  

  • 23. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
    Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
    Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
    Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
    Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
    Schwartz MJ; Hwang DH; Hung AJ; Han J; McClain JW; Shemtov MM; Te AE; Sosa RE; Vaughan ED; Scherr DS
    Cancer; 2008 Apr; 112(8):1718-25. PubMed ID: 18330908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?
    O'Callaghan M; Papa N; Pase M; Frydenberg M; Mark S; Moretti K; Maqsood S; Smith D; Walker T; White C; Millar J;
    BJU Int; 2021 Oct; 128 Suppl 1():6-8. PubMed ID: 33977631
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary care practitioners: an analysis of their perceptions of voiding dysfunction and prostate cancer.
    Plawker MW; Fleisher JM; Nitti VW; Macchia RJ
    J Urol; 1996 Feb; 155(2):601-4. PubMed ID: 8558669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Punishing Physicians for PSA Screening.
    Gomella LG
    Can J Urol; 2015 Dec; 22(6):8042. PubMed ID: 26688130
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
    Pegurri L; Buglione M; Girelli G; Guarnieri A; Meattini I; Ricardi U; Mangoni M; Gabriele P; Bellavita R; Krengli M; Bonetta A; Cagna E; Bunkheila F; Borghesi S; Signor M; Di Marco A; Bertoni F; Stefanacci M; Gatta R; De Bari B; Magrini SM
    Tumori; 2014; 100(1):31-7. PubMed ID: 24675488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
    Moss S; Melia J; Sutton J; Mathews C; Kirby M
    Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Consensus Development Program. Detecting changes in medical practice following a consensus conference on the treatment of prostate cancer.
    Sherman CR; Potosky AL; Weis KA; Ferguson JH
    Int J Technol Assess Health Care; 1992; 8(4):683-93. PubMed ID: 1464488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in patterns of care of prostate cancer, New South Wales, 1991.
    Carson P
    Aust N Z J Surg; 1997 May; 67(5):296-7. PubMed ID: 9152164
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of prostate cancer. Recommendations from the Canadian Urological Association.
    Ramsey EW
    Can J Oncol; 1994 Nov; 4 Suppl 1():82-5. PubMed ID: 8853498
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Current trends in prostate cancer diagnosis and staging among United States urologists.
    Huncharek M; Muscat J
    J Urol; 1998 Aug; 160(2):506. PubMed ID: 9679916
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostate cancer screening and treatment in the transplant population: current status and recommendations.
    Breyer BN; Whitson JM; Freise CE; Meng MV
    J Urol; 2009 May; 181(5):2018-25; discussion 2025-6. PubMed ID: 19286214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.